The New England Signal
Independent journalism covering all six New England states
New Hampshire

Shaheen presses Congress to pass $35 insulin cap during lame-duck session

The New Hampshire Democrat argued that the bill is a clear way for Congress to respond to voters' concerns about the cost of living, her office said.

WASHINGTON — U.S. Sen. Jeanne Shaheen, D-N.H., is pushing Congress to pass her bill capping monthly out-of-pocket insulin costs at $35 during the lame-duck session in Washington, her office said Tuesday.

Shaheen's office circulated a Punchbowl News article that described a bipartisan group of departing lawmakers trying to pass the bill before the session ends. The article called it the group's "last chance" to pass the legislation before they leave Congress.

"Voters sent a clear message this election that Congress needs to take urgent action to lower costs for American families," Shaheen said in a statement quoted in the article. Her office argued that the bill is a clear way for Congress to lower costs after an election in which, it said, voters made the cost of living their top concern.

According to the Punchbowl article, several diabetes advocacy groups, including the American Diabetes Association and the National Kidney Foundation, sent letters to the White House and congressional leaders urging passage of the bill.

The Improving Needed Safeguards for Users of Lifesaving Insulin Now Act, or INSULIN Act, would cap monthly out-of-pocket insulin costs at $35 for Americans with insurance. Her office said it would also expand the effective price cap for people on Medicare. The office described the bill as bipartisan and said it is "closer than ever before" to passing the Senate. According to the office, it advanced out of the Senate Health, Education, Labor and Pensions Committee in July, and companion legislation was introduced in the House in September.

Shaheen is co-chair of the Senate Diabetes Caucus. Her office cited American Diabetes Association polling that it said found 40% of respondents who rely on insulin pay more than $150 a month for it, and 76% of respondents across political parties support a $35 limit on cost sharing.

The release did not include a response from the White House or congressional leaders.

Shaheen has pressed for the bill for weeks. The Signal reported Oct. 2 that she had called for a Senate floor vote on the measure, and on Oct. 9 that her office released a video in which she said 27 states do not cap monthly insulin costs at $35.

The Signal reported Oct. 16 that her office had circulated statements backing the bill from five diabetes and health organizations, including the American Diabetes Association and the National Kidney Foundation.

Earlier coverage: Shaheen calls for Senate floor vote on her bill to cap insulin costs at $35 a month; Shaheen says 27 states lack a $35 insulin cap, presses Senate to pass her INSULIN Act

This brief was drafted by AI from a public agency or political press release and published by The New England Signal. Why we use AI for stories like this one.

New Hampshire